Literature DB >> 11112350

Human uroporphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression.

G Aizencang1, C Solis, D F Bishop, C Warner, R J Desnick.   

Abstract

Uroporphyrinogen-III (URO) synthase is the heme biosynthetic enzyme defective in congenital erythropoietic porphyria. The approximately 34-kb human URO-synthase gene (UROS) was isolated, and its organization and tissue-specific expression were determined. The gene had two promoters that generated housekeeping and erythroid-specific transcripts with unique 5'-untranslated sequences (exons 1 and 2A) followed by nine common coding exons (2B to 10). Expression arrays revealed that the housekeeping transcript was present in all tissues, while the erythroid transcript was only in erythropoietic tissues. The housekeeping promoter lacked TATA and SP1 sites, consistent with the observed low level expression in most cells, whereas the erythroid promoter contained GATA1 and NF-E2 sites for erythroid specificity. Luciferase reporter assays demonstrated that the housekeeping promoter was active in both erythroid K562 and HeLa cells, while the erythroid promoter was active only in erythroid cells and its activity was increased during hemin-induced erythroid differentiation. Thus, human URO-synthase expression is regulated during erythropoiesis by an erythroid-specific alternative promoter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112350     DOI: 10.1006/geno.2000.6373

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  20 in total

1.  High frequency of alternative first exons in erythroid genes suggests a critical role in regulating gene function.

Authors:  Jeff S Tan; Narla Mohandas; John G Conboy
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

Review 2.  One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoans.

Authors:  Iqbal Hamza; Harry A Dailey
Journal:  Biochim Biophys Acta       Date:  2012-05-08

3.  Proteomic analysis of menstrual blood.

Authors:  Heyi Yang; Bo Zhou; Mechthild Prinz; Donald Siegel
Journal:  Mol Cell Proteomics       Date:  2012-07-20       Impact factor: 5.911

Review 4.  Iron metabolism in erythroid cells and patients with congenital sideroblastic anemia.

Authors:  Kazumichi Furuyama; Kiriko Kaneko
Journal:  Int J Hematol       Date:  2017-11-14       Impact factor: 2.490

5.  Feline congenital erythropoietic porphyria: two homozygous UROS missense mutations cause the enzyme deficiency and porphyrin accumulation.

Authors:  Sonia Clavero; David F Bishop; Urs Giger; Mark E Haskins; Robert J Desnick
Journal:  Mol Med       Date:  2010-05-12       Impact factor: 6.354

6.  Congenital erythropoietic porphyria: a novel uroporphyrinogen III synthase branchpoint mutation reveals underlying wild-type alternatively spliced transcripts.

Authors:  David F Bishop; Xiaoye Schneider-Yin; Sonia Clavero; Han-Wook Yoo; Elisabeth I Minder; Robert J Desnick
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

Review 7.  Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis.

Authors:  Achille Iolascon; Luigia De Falco; Carole Beaumont
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

8.  Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions.

Authors:  David F Bishop; Annika Johansson; Robert Phelps; Amr A Shady; Maria C M Ramirez; Makiko Yasuda; Andres Caro; Robert J Desnick
Journal:  Am J Hum Genet       Date:  2006-02-09       Impact factor: 11.025

9.  Lentivirus-mediated gene transfer of uroporphyrinogen III synthase fully corrects the porphyric phenotype in human cells.

Authors:  F Géronimi; E Richard; I Lamrissi-Garcia; M Lalanne; C Ged; I Redonnet-Vernhet; F Moreau-Gaudry; H de Verneuil
Journal:  J Mol Med (Berl)       Date:  2003-04-30       Impact factor: 4.599

10.  Erythroid Krüppel-like factor directly activates the basic Krüppel-like factor gene in erythroid cells.

Authors:  Alister P W Funnell; Christopher A Maloney; Lucinda J Thompson; Janelle Keys; Michael Tallack; Andrew C Perkins; Merlin Crossley
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.